STOK
USDStoke Therapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$25.000
Hoch
$25.550
Tief
$24.660
Volumen
0.81M
Unternehmensfundamentaldaten
Marktkapitalisierung
1.4B
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
1.17M
Börse
NMS
Währung
USD
52-Wochen-Spanne
KI-Analysebericht
Zuletzt aktualisiert: 30. Okt. 2025Stoke Therapeutics (STOK): Riding Wave of Biotech Optimism, But Risks Lurk
Price Action: Volatility With Clear Upside Momentum
The stock has swung between $12.40 and $38.69 over the past 90 days, reflecting high sensitivity to news. Key patterns:
- Explosive breakout in October (up 34% from $20.68 to $27.31 in 4 days, then a dramatic spike to $38.69 on Oct 16)
- Recent correction (-4.3% from Oct 22 to 29) followed by a small rebound on Oct 30 (closing at $31.66 vs. $31.41 open)
- Volume surged to 4x average during the October rally, showing strong institutional interest
News Impact: Positive Clinical Data Drives Surge
Three catalysts fueled the October rally:
Ähnliche Nachrichten
BTIG Reiterates Buy on Stoke Therapeutics, Maintains $39 Price Target
BTIG analyst Thomas Shrader reiterates Stoke Therapeutics with a Buy and maintains $39 price target.
JP Morgan Maintains Neutral on Stoke Therapeutics, Raises Price Target to $25
JP Morgan analyst Jessica Fye maintains Stoke Therapeutics with a Neutral and raises the price target from $15 to $25.
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in
KI-VorhersageBeta
KI-Empfehlung
Aktualisiert am: 5. Nov. 2025, 09:53
69.8% Konfidenz
Risiko & Handel
Einstiegspunkt
$29.88
Gewinnmitnahme
$32.14
Stop-Loss
$27.01
Schlüsselfaktoren
Ähnliche Aktien
SHO
Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc. Common Shares
ENLV
Enlivex Therapeutics Ltd. Ordinary Shares
SNBR
Sleep Number Corporation
FISI
Financial Institutions Inc.
RCC
Ready Capital Corporation 5.75% Senior Notes due 2026
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.